Pramosone Ointment
Product Images NDC 54766-777

3 FDA label images from Sebela Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pramosone (NDC 54766-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure1)

Figure (Figure1)
Chemical structure of hydrocortisone acetate, one of the active ingredients in Pramosone ointment containing hydrocortisone acetate and pramoxine hydrochloride.*
FDA Label Image

Figure (Figure2)

Figure (Figure2)
Chemical structure diagram of pramoxine hydrochloride, displaying the molecular arrangement including the ether and amine groups connected to a benzene ring and a morpholine ring with an HCl molecule.*
FDA Label Image

Label25 (Label25)

Label25 (Label25)
Label for Pramosone ointment containing hydrocortisone acetate 2.5% and pramoxine hydrochloride 1%, topical ointment 2.5%, 1 oz (28.4 g) net weight. The label states that the product is paraben free, for external use only, and includes handling instructions and storage conditions. It is manufactured for Sebela Ireland Ltd. and distributed by Sebela Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.